Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001209191-23-009734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-15 | 2023-02-13 | IART | DAVIS ROBERT T. JR. | EVP, Pres, TT | A - Grant | $0.00 | +7,108 | 45.9K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | A | A | 1,067 | $0.00 | 42,258 | D | — | — | (F2) On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. |
| 2 | Common | Common Stock | 2023-02-13 | A | A | 1,779 | $0.00 | 44,037 | D | — | — | (F2) On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. |
| 3 | Common | Common Stock | 2023-02-13 | A | A | 2,379 | $0.00 | 41,191 | D | — | — | (F1) On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. |
| 4 | Common | Common Stock | 2023-02-13 | A | A | 1,883 | $0.00 | 45,920 | D | — | — | (F3) On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. |